Author
Mattias Duytschaever
Also Known As
DUYTSCHAEVER M, Daniel Dendooven, Dr. Mattias Duytschaever, Duytschaever, Mattias, M DUYTSCHAEVER, M Duytschaever, M. Duytschaever, MATTIAS DUYTSCHAEVER, MATTIAS F. DUYTSCHAEVER, Margot Vloka
261
Publications
13.6K
Citations
45
H-Index
52
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 17 | 23 | 4.3K |
2 | Public Health | 10 | 10 | 949 |
3 | Health Sciences | 2 | 2 | 116 |
4 | Education | 1 | 1 | 17 |
5 | Engineering | 1 | 1 | 18 |
Mattias Duytschaever
×
94
Publications
10.7K
Citations
42
H-Index
| Year | Citations | |
|---|---|---|
2017 | 2.7K | |
2014 | 1.4K | |
2017 | 700 | |
2024 | 443 | |
2018 | 350 | |
2017 | 339 | |
2024 | 308 | |
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, ThrombosisDose-finding Phase 2Cardiovascular DiseasePharmacologyCardiovascular Pharmacology | 2022 | 296 |
2019 | 284 | |
2017 | 206 |
Page 1
Page 1